CKD-MBD: an endless story
Diego Brancaccio1, Mario Cozzolino
1Renal Unit Simone Martini, Milan, Italy. diego.brancaccio@tiscalinet.it
Insights
Chronic kidney disease (CKD) patients often develop mineral bone disorders (MBD) and cardiovascular issues due to altered calcium-phosphate metabolism. This review updates understanding of CKD-MBD pathogenesis and treatment strategies.
Area of Science:
- Nephrology
- Endocrinology
- Cardiology
Background:
- Chronic kidney disease (CKD) affects a large population, causing significant social impact.
- CKD complications include mineral bone disorders (MBD) and cardiovascular diseases.
- Early derangements in calcium-phosphate (Ca-P) metabolism, phosphate homeostasis, and reduced calcitriol synthesis are critical in CKD patients.
Purpose of the Study:
- To review recent contributions to the understanding of CKD-MBD.
- To update knowledge on the pathogenetic mechanisms of CKD-MBD.
- To discuss the most appropriate therapeutic approaches for CKD-MBD.
Main Methods:
- Literature review of recent scientific contributions.
- Analysis of observational studies on vitamin D receptor activators.
- Examination of novel mechanisms in secondary hyperparathyroidism.
Main Results:
- Vitamin D receptor activators may offer cardiovascular and metabolic benefits beyond lowering parathyroid hormone.
- The treatment of secondary hyperparathyroidism is complex, involving cinacalcet hydrochloride and new pathogenetic insights.
Conclusions:
- Understanding CKD-MBD pathogenesis is crucial for effective management.
- Novel therapeutic strategies are emerging for secondary hyperparathyroidism in CKD.
- Integrated approaches are needed to address the multifaceted complications of CKD.
Abstract:
Renal failure is a growing problem that involves a large part of the population and has a great social impact, with often incapacitating complications, mainly related to mineral bone disorders (MBD) and cardiovascular diseases. Analysis of the recent scientific literature confirms that a large number of chronic kidney disease (CKD) patients develop an early derangement of the parameters of Ca-P metabolism in which phosphate homeostasis and a reduced endogenous synthesis of calcitriol play a critical role. Recent findings from several large observational studies have also suggested that the benefits of vitamin D receptor activators may extend beyond the traditional parathyroid hormone-lowering effect, and could result in direct cardiovascular and metabolic benefits. Treatment of secondary hyperparathyroidism has become even more complex with the arrival of the calcium-sensing receptor agonist cinacalcet hydrochloride and with the uncovering of novel mechanisms responsible for secondary hyperparathyroidism. The aim of this review is the analysis of some of the recent contributions in the field of CKD-MBD, to update the understanding of the pathogenetic mechanisms and possibly the most appropriate therapeutic approach in this field.
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules
Positive Regulator Molecules
Diabetic Ketoacidosis l: Introduction
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.

